Centogene (NASDAQ:CNTG) Short Interest Update

Centogene (NASDAQ:CNTGGet Free Report) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 11,900 shares, a growth of 5.3% from the March 15th total of 11,300 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 44,800 shares, the days-to-cover ratio is presently 0.3 days.

Centogene Price Performance

CNTG stock opened at $0.47 on Thursday. The firm has a 50 day simple moving average of $0.73 and a 200-day simple moving average of $1.02. Centogene has a twelve month low of $0.46 and a twelve month high of $2.52.

About Centogene

(Get Free Report)

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.

Featured Articles

Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.